Latest in Novo Nordisk's Wegovy
Sort by
5 items
-
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 1d -
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.CBS News - 1d -
Novo’s Weight Loss Drugs Removed from FDA Shortage List
The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.Inc. - 5h -
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.MarketWatch - 1d -
Ozempic and Wegovy officially moved off FDA's drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...The Hill - 1d